Bambusa Therapeutics grants CEO Shanshan Xu 758,204 performance-based restricted stock units
BBTX•Bambusa Therapeutics granted CEO Shanshan Xu 758,204 restricted stock units and 379,102 stock options on Oct. 29, 2026.
1. Equity awards
Bambusa Therapeutics granted CEO Shanshan Xu 758,204 restricted stock units and 379,102 stock options on Oct. 29, 2026.
